Burosumab

MCE 国际站：Burosumab

CAS：1610833-03-8

品牌：MedChemExpress (MCE)

存储条件：Please store the product under the recommended conditions in the Certificate of Analysis.

生物活性：Burosumab 是一种人 FGF23 中和抗体，可用于 X 连锁低磷血症 (XLH) 和肿瘤导致的骨软化的研究。

热销产品：WNK463 | Semaglutide (TFA) | Eriodictyol | Elaiophylin | Hydroxysafflor yellow A | Clopidogrel | Diosmetin | Tariquidar | Rhodamine 123 | DPPC

研究领域：Others

作用靶点：Others

热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸

Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides

参考文献：
[1]. Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) ａnd Other Conditions in Adults ａnd Children. Front Endocrinol (Lausanne). 2020 May 28;11:338.
[2]. Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1.